Propranolol Hydrochloride Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Propranolol Hydrochloride Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 10/31/2023. Reported reason: Shortage of an active ingredient

Shortage Details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0143-9872-10
Dosage Form
Injection
Presentation
Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 0143-9872-10)
Initial Posting
10/31/2023
Revised Date

Reason

Shortage of an active ingredient